Carregant...
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
BACKGROUND: Higher-order structure (HOS) assessment is an important component of biosimilarity evaluations. While established spectroscopic methods are routinely used to characterize structure and evaluate similarity, the addition of X-ray crystallographic analysis to these biophysical methods enabl...
Guardat en:
| Publicat a: | BioDrugs |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985046/ https://ncbi.nlm.nih.gov/pubmed/31650490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-019-00390-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|